首页 > 最新文献

EJC paediatric oncology最新文献

英文 中文
Familial risks and incidence rates for childhood nervous system tumors in Sweden 瑞典儿童神经系统肿瘤的家族风险和发病率
Pub Date : 2025-12-01 Epub Date: 2025-07-08 DOI: 10.1016/j.ejcped.2025.100310
Kari Hemminki , Xinjun Li , Kristina Sundquist , Jan Sundquist , Steffen Hirsch , Jianguang Ji , Akseli Hemminki , Asta Försti

Background

Childhood (< 20 years) nervous system tumors manifest in some rare cancer syndromes but how commonly they present with familial clustering between various histological types is not well known at a nation-wide level. Our aim is to enhance understanding of familial risks in childhood nervous system cancers.

Methods

We used the Swedish population and cancer data from years 1958–2021 to address familial risks among nervous system cancers when the case was diagnosed before age 20 years but the proband could be diagnosed at any age. Adjusted familial (relative) risks were expressed as standardized incidence ratios (SIRs).

Results

Familial childhood cancer cases amounted to 123 in the brain, 15 in the spinal cord and 9 in peripheral nerves. Familial risk for concordant brain cancer was about 2.0 irrespective of proband. Concordant risk of spinal cord cancer was high when mothers (17.92) or siblings were probands (24.91). High familial risk of 34.53 was recorded for hemangioblastoma, and moderate high risks were observed also for schwannoma (4.07), ependymoblastoma (3.48) and female ganglioneuroma (7.72) whereas astrocytoma risks were at the level of common cancers at other sites (1.7–2.0). Hemangioblastoma families appeared not to be related to von Hippel-Lindau syndrome because of lack of pathognomonic signs other than hemangioblastoma in the families.

Conclusion

In spite of the low number of childhood nervous system tumors, we observed high familial risks for, probably novel, syndromic hemangioblastoma, and schwannomas for which concordant clusters were found particularly in the spinal cord. Inquiring about a detailed family history at diagnosis of a nervous system cancer in childhood may reveal a syndromic disease due to a constitutional variant amenable to treatment.
BackgroundChildhood (& lt;20年来,神经系统肿瘤表现为一些罕见的癌症综合征,但在全国范围内,它们以不同组织学类型的家族聚类表现的普遍程度尚不清楚。我们的目的是加强对儿童神经系统癌症家族风险的理解。方法:我们使用1958-2021年的瑞典人口和癌症数据 ,研究在20岁之前诊断出神经系统癌症的病例的家族性风险,但先证者可以在任何年龄诊断。调整后的家族(相对)风险以标准化发病率比(SIRs)表示。结果家族性儿童肿瘤中,脑部123例,脊髓15例,周围神经9例。与先证者无关,患一致性脑癌的家族风险约为2.0。当母亲(17.92)或兄弟姐妹是先证者(24.91)时,脊髓癌的一致性风险较高。血管母细胞瘤的家族性风险为34.53,神经鞘瘤(4.07)、室管膜母细胞瘤(3.48)和女性神经节神经瘤(7.72)的家族性风险为中等,而星形细胞瘤的家族性风险与其他部位的常见癌症相同(1.7-2.0)。血管母细胞瘤家族似乎与von Hippel-Lindau综合征无关,因为在这些家族中除了血管母细胞瘤外没有其他病理征象。结论尽管儿童神经系统肿瘤的发生率较低,但我们观察到,综合征型血管母细胞瘤和神经鞘瘤的家族性风险较高,尤其是在脊髓中发现了一致性簇状瘤。在诊断儿童神经系统癌症时询问详细的家族史,可能会发现由于体质变异而导致的综合征性疾病。
{"title":"Familial risks and incidence rates for childhood nervous system tumors in Sweden","authors":"Kari Hemminki ,&nbsp;Xinjun Li ,&nbsp;Kristina Sundquist ,&nbsp;Jan Sundquist ,&nbsp;Steffen Hirsch ,&nbsp;Jianguang Ji ,&nbsp;Akseli Hemminki ,&nbsp;Asta Försti","doi":"10.1016/j.ejcped.2025.100310","DOIUrl":"10.1016/j.ejcped.2025.100310","url":null,"abstract":"<div><h3>Background</h3><div>Childhood (&lt; 20 years) nervous system tumors manifest in some rare cancer syndromes but how commonly they present with familial clustering between various histological types is not well known at a nation-wide level. Our aim is to enhance understanding of familial risks in childhood nervous system cancers.</div></div><div><h3>Methods</h3><div>We used the Swedish population and cancer data from years 1958–2021 to address familial risks among nervous system cancers when the case was diagnosed before age 20 years but the proband could be diagnosed at any age. Adjusted familial (relative) risks were expressed as standardized incidence ratios (SIRs).</div></div><div><h3>Results</h3><div>Familial childhood cancer cases amounted to 123 in the brain, 15 in the spinal cord and 9 in peripheral nerves. Familial risk for concordant brain cancer was about 2.0 irrespective of proband. Concordant risk of spinal cord cancer was high when mothers (17.92) or siblings were probands (24.91). High familial risk of 34.53 was recorded for hemangioblastoma, and moderate high risks were observed also for schwannoma (4.07), ependymoblastoma (3.48) and female ganglioneuroma (7.72) whereas astrocytoma risks were at the level of common cancers at other sites (1.7–2.0). Hemangioblastoma families appeared not to be related to von Hippel-Lindau syndrome because of lack of pathognomonic signs other than hemangioblastoma in the families.</div></div><div><h3>Conclusion</h3><div>In spite of the low number of childhood nervous system tumors, we observed high familial risks for, probably novel, syndromic hemangioblastoma, and schwannomas for which concordant clusters were found particularly in the spinal cord. Inquiring about a detailed family history at diagnosis of a nervous system cancer in childhood may reveal a syndromic disease due to a constitutional variant amenable to treatment.</div></div>","PeriodicalId":94314,"journal":{"name":"EJC paediatric oncology","volume":"6 ","pages":"Article 100310"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144605535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A multi-dimensional approach to recognize genetic predisposition in children with acute lymphoblastic leukemia 识别儿童急性淋巴细胞白血病遗传易感性的多维方法
Pub Date : 2025-12-01 Epub Date: 2025-09-09 DOI: 10.1016/j.ejcped.2025.100320
Stefanie V. Junk , Laura R. Bettini , Katharina Daugs , Melina Mescher , Marjolijn C.J. Jongmans , Arndt Borkhardt , Giovanni Cazzaniga , Roland P. Kuiper , Jette J. Bakhuizen
Pediatric acute lymphoblastic leukemia (ALL) is the most common childhood cancer, with significant advances in treatment leading to high cure rates. Recent studies have highlighted the importance of genetic predisposition in ALL. Identifying contributing heritable or de novo genetic factors is crucial for potential treatment modifications, early detection of second malignant neoplasms (SMNs) and genetic counseling for surveillance of patients and family members. Multiple syndromes, such as Down syndrome (DS) or Ataxia Telangiectasia (AT), are known to give rise to increased risk for developing ALL. Most of these syndromes can be recognized by the presence of specific clinical features. However, a notable proportion of patients harboring (likely) pathogenic germline variants in cancer predisposition genes (CPGs) can easily be missed due to the absence of these characteristics. Therefore, the diagnosis of cancer predisposition syndromes (CPS) requires multiple approaches that are based on phenotypic characteristics, germline genetic analysis and genomic characterization of the leukemia samples. Despite the recognized benefits, routine screening for germline variants has not yet been implemented in large study groups due to logistical and financial challenges. This review emphasizes the importance of integrating systematic genetic testing into standard care protocols for ALL patients and summarizes current practical considerations for CPS identification in children with ALL.
小儿急性淋巴细胞白血病(ALL)是最常见的儿童癌症,在治疗方面取得了重大进展,导致治愈率很高。最近的研究强调了遗传易感性在ALL中的重要性。确定起作用的遗传或新生遗传因素对于潜在的治疗修改、早期发现第二恶性肿瘤(SMNs)以及为患者和家庭成员的监测提供遗传咨询至关重要。多种综合征,如唐氏综合征(DS)或共济失调毛细血管扩张症(AT),已知会增加患ALL的风险。大多数这些综合征可以通过存在特定的临床特征来识别。然而,由于缺乏这些特征,在癌症易感基因(CPGs)中携带(可能)致病性种系变异的显著比例的患者很容易被遗漏。因此,癌症易感综合征(CPS)的诊断需要基于白血病样本的表型特征、种系遗传分析和基因组特征的多种方法。尽管有公认的好处,但由于后勤和财政方面的挑战,对生殖系变异的常规筛查尚未在大型研究小组中实施。本综述强调了将系统基因检测纳入ALL患者标准治疗方案的重要性,并总结了目前ALL患儿CPS鉴定的实际考虑。
{"title":"A multi-dimensional approach to recognize genetic predisposition in children with acute lymphoblastic leukemia","authors":"Stefanie V. Junk ,&nbsp;Laura R. Bettini ,&nbsp;Katharina Daugs ,&nbsp;Melina Mescher ,&nbsp;Marjolijn C.J. Jongmans ,&nbsp;Arndt Borkhardt ,&nbsp;Giovanni Cazzaniga ,&nbsp;Roland P. Kuiper ,&nbsp;Jette J. Bakhuizen","doi":"10.1016/j.ejcped.2025.100320","DOIUrl":"10.1016/j.ejcped.2025.100320","url":null,"abstract":"<div><div>Pediatric acute lymphoblastic leukemia (ALL) is the most common childhood cancer, with significant advances in treatment leading to high cure rates. Recent studies have highlighted the importance of genetic predisposition in ALL. Identifying contributing heritable or <em>de novo</em> genetic factors is crucial for potential treatment modifications, early detection of second malignant neoplasms (SMNs) and genetic counseling for surveillance of patients and family members. Multiple syndromes, such as Down syndrome (DS) or Ataxia Telangiectasia (AT), are known to give rise to increased risk for developing ALL. Most of these syndromes can be recognized by the presence of specific clinical features. However, a notable proportion of patients harboring (likely) pathogenic germline variants in cancer predisposition genes (CPGs) can easily be missed due to the absence of these characteristics. Therefore, the diagnosis of cancer predisposition syndromes (CPS) requires multiple approaches that are based on phenotypic characteristics, germline genetic analysis and genomic characterization of the leukemia samples. Despite the recognized benefits, routine screening for germline variants has not yet been implemented in large study groups due to logistical and financial challenges. This review emphasizes the importance of integrating systematic genetic testing into standard care protocols for ALL patients and summarizes current practical considerations for CPS identification in children with ALL.</div></div>","PeriodicalId":94314,"journal":{"name":"EJC paediatric oncology","volume":"6 ","pages":"Article 100320"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145049360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CLINICAL SPECTRUM OF AN EGYPTIAN COHORT OF CHILDREN WITH MYELODYSPLASTIC SYNDROME 埃及骨髓增生异常综合征儿童队列的临床谱
Pub Date : 2025-12-01 Epub Date: 2025-11-04 DOI: 10.1016/j.ejcped.2025.100405
Sara Mostafa Makkeyah , Marwa Waheed Tolba , Elshahhat Ahmed , Menna Allah Zakaria Abou Elwafa , Nihal Hussien Aly
{"title":"CLINICAL SPECTRUM OF AN EGYPTIAN COHORT OF CHILDREN WITH MYELODYSPLASTIC SYNDROME","authors":"Sara Mostafa Makkeyah ,&nbsp;Marwa Waheed Tolba ,&nbsp;Elshahhat Ahmed ,&nbsp;Menna Allah Zakaria Abou Elwafa ,&nbsp;Nihal Hussien Aly","doi":"10.1016/j.ejcped.2025.100405","DOIUrl":"10.1016/j.ejcped.2025.100405","url":null,"abstract":"","PeriodicalId":94314,"journal":{"name":"EJC paediatric oncology","volume":"6 ","pages":"Article 100405"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145428430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CLINICAL CHARACTERISTICS AND OUTCOMES IN CHILDREN WITH SEVERE APLASTIC ANEMIA WHO RECEIVED IMMUNOMODULATORY THERAPY AND/OR TRANSPLANTATION AT THE MISERICORDIA PEDIATRIC HOSPITAL FOUNDATION 2015 TO 2024 2015 - 2024年在misericordia儿科医院基金会接受免疫调节治疗和/或移植的严重再生障碍性贫血儿童的临床特征和结局
Pub Date : 2025-12-01 Epub Date: 2025-11-04 DOI: 10.1016/j.ejcped.2025.100366
Angelica Maria Delgado Beltran
{"title":"CLINICAL CHARACTERISTICS AND OUTCOMES IN CHILDREN WITH SEVERE APLASTIC ANEMIA WHO RECEIVED IMMUNOMODULATORY THERAPY AND/OR TRANSPLANTATION AT THE MISERICORDIA PEDIATRIC HOSPITAL FOUNDATION 2015 TO 2024","authors":"Angelica Maria Delgado Beltran","doi":"10.1016/j.ejcped.2025.100366","DOIUrl":"10.1016/j.ejcped.2025.100366","url":null,"abstract":"","PeriodicalId":94314,"journal":{"name":"EJC paediatric oncology","volume":"6 ","pages":"Article 100366"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145428552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
WHEN A “ZERO” CAN BE A DIAGNOSIS IN PEDIATRICS 在儿科,什么时候“零”可以作为诊断
Pub Date : 2025-12-01 Epub Date: 2025-11-04 DOI: 10.1016/j.ejcped.2025.100378
Elena Sebastián, Alejandro Sanz, Josune Zubicaray, Guzmán Lopez, Julián Sevilla
{"title":"WHEN A “ZERO” CAN BE A DIAGNOSIS IN PEDIATRICS","authors":"Elena Sebastián,&nbsp;Alejandro Sanz,&nbsp;Josune Zubicaray,&nbsp;Guzmán Lopez,&nbsp;Julián Sevilla","doi":"10.1016/j.ejcped.2025.100378","DOIUrl":"10.1016/j.ejcped.2025.100378","url":null,"abstract":"","PeriodicalId":94314,"journal":{"name":"EJC paediatric oncology","volume":"6 ","pages":"Article 100378"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145428564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IMPROVED DISEASE FREE SURVIVAL IN JMML. THE DUTCH EXPERIENCE. 提高jmml的无病生存率。荷兰的经验。
Pub Date : 2025-12-01 Epub Date: 2025-11-04 DOI: 10.1016/j.ejcped.2025.100383
Dorine Bresters , Valérie de Haas , Martine Mol , Katja Heitink , Arjenne Kors , Mirjam Belderbos , Marco Koudijs , Esmé Waanders , Kirsten Thus , Marc Bierings
{"title":"IMPROVED DISEASE FREE SURVIVAL IN JMML. THE DUTCH EXPERIENCE.","authors":"Dorine Bresters ,&nbsp;Valérie de Haas ,&nbsp;Martine Mol ,&nbsp;Katja Heitink ,&nbsp;Arjenne Kors ,&nbsp;Mirjam Belderbos ,&nbsp;Marco Koudijs ,&nbsp;Esmé Waanders ,&nbsp;Kirsten Thus ,&nbsp;Marc Bierings","doi":"10.1016/j.ejcped.2025.100383","DOIUrl":"10.1016/j.ejcped.2025.100383","url":null,"abstract":"","PeriodicalId":94314,"journal":{"name":"EJC paediatric oncology","volume":"6 ","pages":"Article 100383"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145428569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COMPREHENSIVE CHARACTERIZATION OF SOMATIC PTPN11-MUTATED JMML 体细胞ptpn11突变JMML的综合鉴定
Pub Date : 2025-12-01 Epub Date: 2025-11-04 DOI: 10.1016/j.ejcped.2025.100341
Edoardo Muratore , Valérie de Haas , Dorine Bresters , Christian Flotho , Pierre Goncalves , Mattias Hofmans , Marko Kavcic , Tim Lammens , Daniel B. Lipka , Loizos Petrikkos , Charlotte M. Niemeyer , for the EWOG-MDS JMML Working Group Peter Nöllke , Senthilkumar Ramamoorthy , Dirk Lebrecht , Riccardo Masetti , Maximilian Schönung , EWOG-MDS National Coordinators for EWOG-MDS
{"title":"COMPREHENSIVE CHARACTERIZATION OF SOMATIC PTPN11-MUTATED JMML","authors":"Edoardo Muratore ,&nbsp;Valérie de Haas ,&nbsp;Dorine Bresters ,&nbsp;Christian Flotho ,&nbsp;Pierre Goncalves ,&nbsp;Mattias Hofmans ,&nbsp;Marko Kavcic ,&nbsp;Tim Lammens ,&nbsp;Daniel B. Lipka ,&nbsp;Loizos Petrikkos ,&nbsp;Charlotte M. Niemeyer ,&nbsp;for the EWOG-MDS JMML Working Group Peter Nöllke ,&nbsp;Senthilkumar Ramamoorthy ,&nbsp;Dirk Lebrecht ,&nbsp;Riccardo Masetti ,&nbsp;Maximilian Schönung ,&nbsp;EWOG-MDS National Coordinators for EWOG-MDS","doi":"10.1016/j.ejcped.2025.100341","DOIUrl":"10.1016/j.ejcped.2025.100341","url":null,"abstract":"","PeriodicalId":94314,"journal":{"name":"EJC paediatric oncology","volume":"6 ","pages":"Article 100341"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145428514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MYELODYSPLASTIC SYNDROME IN CHILDHOOD: THE HACETTEPE COHORT 儿童骨髓增生异常综合征:hacettepe队列
Pub Date : 2025-12-01 Epub Date: 2025-11-04 DOI: 10.1016/j.ejcped.2025.100407
Tekin Aksu, Fatma Ugur, Sule Unal, Barış Kuskonmaz, Selin Aytac
{"title":"MYELODYSPLASTIC SYNDROME IN CHILDHOOD: THE HACETTEPE COHORT","authors":"Tekin Aksu,&nbsp;Fatma Ugur,&nbsp;Sule Unal,&nbsp;Barış Kuskonmaz,&nbsp;Selin Aytac","doi":"10.1016/j.ejcped.2025.100407","DOIUrl":"10.1016/j.ejcped.2025.100407","url":null,"abstract":"","PeriodicalId":94314,"journal":{"name":"EJC paediatric oncology","volume":"6 ","pages":"Article 100407"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145428625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THE GENOMIC LANDSCAPE OF JUVENILE MYELOMONOCYTIC LEUKEMIA ON WHOLE EXOME SEQUENCING 基于全外显子组测序的青少年髓细胞白血病基因组景观
Pub Date : 2025-12-01 Epub Date: 2025-11-04 DOI: 10.1016/j.ejcped.2025.100408
Aditya Kumar Gupta , Ravi Kumar Majhi , Harsh Goel , Harshita Makkar , Pranay Tanwar , Anita Chopra , Meena Jagdish Prasad , Sameer Bhakshi , Seth Rachna
{"title":"THE GENOMIC LANDSCAPE OF JUVENILE MYELOMONOCYTIC LEUKEMIA ON WHOLE EXOME SEQUENCING","authors":"Aditya Kumar Gupta ,&nbsp;Ravi Kumar Majhi ,&nbsp;Harsh Goel ,&nbsp;Harshita Makkar ,&nbsp;Pranay Tanwar ,&nbsp;Anita Chopra ,&nbsp;Meena Jagdish Prasad ,&nbsp;Sameer Bhakshi ,&nbsp;Seth Rachna","doi":"10.1016/j.ejcped.2025.100408","DOIUrl":"10.1016/j.ejcped.2025.100408","url":null,"abstract":"","PeriodicalId":94314,"journal":{"name":"EJC paediatric oncology","volume":"6 ","pages":"Article 100408"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145428626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SILENT CONVERSATIONS: JMML'S INTERPLAY WITH T CELL 沉默的对话:jml与t细胞的相互作用
Pub Date : 2025-12-01 Epub Date: 2025-11-04 DOI: 10.1016/j.ejcped.2025.100415
Jovana Rajak , Ke Meng , Anna Lena Sippel , Jun Wang , Naile Koleci , Alexandra Emilia Schlaak , Hui Xiao , Riccardo Masseti , Christian Flotho , Charlotte M. Niemeyer , Luciana Hannibal , Bertram Bengsch , Miriam Erlacher
{"title":"SILENT CONVERSATIONS: JMML'S INTERPLAY WITH T CELL","authors":"Jovana Rajak ,&nbsp;Ke Meng ,&nbsp;Anna Lena Sippel ,&nbsp;Jun Wang ,&nbsp;Naile Koleci ,&nbsp;Alexandra Emilia Schlaak ,&nbsp;Hui Xiao ,&nbsp;Riccardo Masseti ,&nbsp;Christian Flotho ,&nbsp;Charlotte M. Niemeyer ,&nbsp;Luciana Hannibal ,&nbsp;Bertram Bengsch ,&nbsp;Miriam Erlacher","doi":"10.1016/j.ejcped.2025.100415","DOIUrl":"10.1016/j.ejcped.2025.100415","url":null,"abstract":"","PeriodicalId":94314,"journal":{"name":"EJC paediatric oncology","volume":"6 ","pages":"Article 100415"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145428633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
EJC paediatric oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1